ND CHANGE IN PLASMA LYSO GL3 AND RELIEF OF GASTRO INTESTINAL SYMPTOMS IN PATIENTS SWITCHED FROM AGALSIDASE ALFA TO AGALSIDASE BETA
Latest Information Update: 11 Nov 2020
At a glance
- Drugs Agalsidase beta (Primary)
- Indications Fabry's disease
- Focus Biomarker; Therapeutic Use
- 11 Nov 2020 New trial record